Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sifen Wang

Showing results (11-20 of 15) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 15 results.
The Oncologist|November 25, 2024
Induction chemotherapy plus chemoradiotherapy in esophageal cancer: long-term results and exploratory analyses of a randomized controlled trialShiliang Liu, Baoqing Chen, Yujia Zhu, et al.
The Lancet. Oncology|March 29, 2023
Toripalimab combined with definitive chemoradiotherapy in locally advanced oesophageal squamous cell carcinoma (EC-CRT-001): a single-arm, phase 2 trialYujia Zhu, Jing Wen, Qiaoqiao Li, et al.
Journal of Advanced Research|July 3, 2024
RNA modification gene WDR4 facilitates tumor progression and immunotherapy resistance in breast cancerYongzhou Luo, Wenwen Tian, Da Kang, et al.
Journal for Immunotherapy of Cancer|January 12, 2026
Serum cytokines predict response and survival in esophageal squamous cell carcinoma receiving chemoradiotherapy combined with anti-PD-1 antibody: analyses of two phase II clinical trialsBaoQing Chen, Junying Chen, Sifen Wang, et al.
International Journal of Radiation Oncology, Biology, Physics|June 27, 2024
Comparison of Efficacy and Safety of Combined Chemoimmunotherapy With or Without Radiation Therapy for Stage IVB Esophageal Squamous Cell Carcinoma: A Multicenter Propensity Score Matching AnalysisBiqi Chen, Wenyan Chen, Qi Cheng, et al.
Pageof 2

Showing results (11-20 of 15) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 15 results.
The Oncologist|November 25, 2024
Induction chemotherapy plus chemoradiotherapy in esophageal cancer: long-term results and exploratory analyses of a randomized controlled trialShiliang Liu, Baoqing Chen, Yujia Zhu, et al.
The Lancet. Oncology|March 29, 2023
Toripalimab combined with definitive chemoradiotherapy in locally advanced oesophageal squamous cell carcinoma (EC-CRT-001): a single-arm, phase 2 trialYujia Zhu, Jing Wen, Qiaoqiao Li, et al.
Journal of Advanced Research|July 3, 2024
RNA modification gene WDR4 facilitates tumor progression and immunotherapy resistance in breast cancerYongzhou Luo, Wenwen Tian, Da Kang, et al.
Journal for Immunotherapy of Cancer|January 12, 2026
Serum cytokines predict response and survival in esophageal squamous cell carcinoma receiving chemoradiotherapy combined with anti-PD-1 antibody: analyses of two phase II clinical trialsBaoQing Chen, Junying Chen, Sifen Wang, et al.
International Journal of Radiation Oncology, Biology, Physics|June 27, 2024
Comparison of Efficacy and Safety of Combined Chemoimmunotherapy With or Without Radiation Therapy for Stage IVB Esophageal Squamous Cell Carcinoma: A Multicenter Propensity Score Matching AnalysisBiqi Chen, Wenyan Chen, Qi Cheng, et al.
Pageof 2